This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Joann Lau
Microbiology Engineer at Genentech
Speaker

Profile


Joann received a bachelors of science in Medical Microbiology at the University of California Davis. She has over 10 years of professional experience in microbial contamination control for commercial small molecule and clinical phases adaptive cell therapy and oligonucleotides. In 2021 Joann joined Genentech’s Pharma Technical Quality chapter as a microbiology engineer with the focus to build out the end to end microbial control strategy for oligonucleotides at Genentech.

Agenda Sessions

  • Lessons Learned for Applying a Holistic Microbial Control Process for Oligonucleotides in Process Control Excursions

    2:30pm